The path towards validating Tibetan and Chinese medicine by the food and drug administration

Abstract

In recent years, the United State’s increasing reliance on Tibetan health practitioners is evidenced by the public’s interest in an alternative to conventional Western medicine. Tibetan medicine has been integrated into and has made large contributions to the U.S. Healthcare system and yet despite all of this recognition and support, Tibetan medicine remains unregulated by US Health and Drug agencies. Measures and guidelines, with exemplars from Germany’s management of botanical medicines, will be used to evaluate how Tibetan medicine meets and exceeds federal standards of medical safety and protection. The results of which will contribute to the public’s knowledge and increase incentives for ongoing research. The ultimate goal is to change the U.S States’ attitude about Eastern medicines so much so that they gain regulation from the Federal Drug Administration.